Navigation Links
SGX Pharmaceuticals to Present at Three Upcoming Investor Conferences
Date:10/30/2007

SAN DIEGO, Oct. 30 /PRNewswire-FirstCall/ -- SGX Pharmaceuticals, Inc. (Nasdaq: SGXP) announced today that the company will be presenting at three upcoming investor conferences during which Mike Grey, president & chief executive officer of SGX Pharmaceuticals, will provide a corporate overview on the Company's oncology pipeline. The conference information is as follows:

-- BIOCOM Investor Conference Presentation: Thursday, November 1, 2007,

at 9:00 AM Pacific Daylight Time at the Marriott Del Mar in San Diego.

-- Rodman & Renshaw 9th Annual Healthcare Conference Presentation:

Wednesday, November 7, 2007 at 8:50 AM Eastern Standard Time at the New

York Palace Hotel, New York City.

-- CIBC 18th Annual Healthcare Conference Presentation: Wednesday,

November 7, 2007 at 10:55 AM Eastern Standard Time at the Waldorf-

Astoria Hotel in New York City.

A live webcast of the Rodman & Renshaw presentation will be available under the investor relations section of the Company's website at http://www.sgxpharma.com. Replays of the presentation will be available for 90 days following the event. Please connect to the Company's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.

About SGX Pharmaceuticals

SGX Pharmaceuticals is a biotechnology company focused on the discovery, development and commercialization of innovative cancer therapeutics. The SGX oncology pipeline includes drug candidates from its FAST(TM) drug discovery platform, such as next generation BCR-ABL inhibitors being developed by SGX and in partnership with Novartis and MET tyrosine kinase inhibitors, including SGX523, and potent JAK2 inhibitors. More information on the pipeline and drug discovery platform can be found at http://www.sgxpharma.com and in the Company's various filings with the Securities and Exchange Commission.


'/>"/>
SOURCE SGX Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Supply of Radiopharmaceuticals Hampered by Attacks
2. FDA approves Watson Pharmaceuticals Oxytrol patch
3. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
4. Antigenics Pharmaceuticals plans for Phase III trial of its Melanoma vaccine
5. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
6. Top Pharmaceuticals Influence Doctors Prescriptions
7. More Study On Side Effects of ADHD Drug Needed: Shire Pharmaceuticals
8. Personalized Medicine and Innovative Pharmaceuticals
9. New lease of life for asthmatics by Accentia Biopharmaceuticals
10. Pravastatin Launched by Watson Pharmaceuticals
11. Tata Industries picks up stake in Indigene Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2017)... ... , ... Offering the purest product of its kind, Swissx Labs AG has ... than the market has seen before. Swissx uses proprietary strains of hemp plants grown ... process for extraction, to produce its CBD oil--maximizing its benefits for health and wellness. ...
(Date:4/27/2017)... ... April 27, 2017 , ... Plastic Surgery Associates is excited to announce that ... at the upcoming Aesthetic Meeting. Held in San Diego, at the San Diego Convention ... will lend their expertise to the Premier Global Hot Topics session, speaking on genital ...
(Date:4/26/2017)... ... April 26, 2017 , ... Intalere, ... released the podcast, “Make Plans for MACRA,” highlighting the impact of ... physician's office and how physicians and other clinicians are reimbursed for the care ...
(Date:4/26/2017)... (PRWEB) , ... April 26, ... ... (ATA) is thrilled to announce the ATA 2017 President’s Awards recipients, comprised ... and demonstrated superior healthcare delivery. , The ATA 2017 President’s Awards ...
(Date:4/26/2017)... ... April 26, 2017 , ... Datos Health , developer of a pioneering ... , the largest Electronic Medical Records (EMR) provider in South Africa. By using ... a patient’s remote health progress, empowering the patient to take direct responsibility for their ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... Research and Markets has announced the ... Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies ... ... was valued at US$ 7,167.6 Mn in 2015, and is ... a CAGR of 5.6% from 2016 to 2024. ...
(Date:4/20/2017)... LUND, Sweden , April 20, 2017 /PRNewswire/ ... OTCQX: NEVPF) ("NeuroVive") today announced positive preclinical ... company,s preclinical compound for non-alcoholic steatohepatitis (NASH), ... NV556 has previously ... STAM™ NASH model. Today, NeuroVive,s scientists present ...
(Date:4/19/2017)... CRH) (NYSE MKT: CRHM) (the "Company"), announces that it will participate ... the Sheraton Hotel in Toronto, Ontario . ... is scheduled to present on Tuesday, May 2 at 10:00 am. ... the Board, Tony Holler will also attend the event. ... For more details about the ...
Breaking Medicine Technology: